Researcher
Marc Peeters
- Research interest:My expertise is in the field of oncology or cancer research. It is mainly focused on clinical translational research. This domain is very broad and ranges from bio-research to clinical studies
- Keywords:ONCOLOGY, Medicine
- Disciplines:Cancer therapy , Cancer biology, Cancer diagnosis, Cancer epidemiology, Cancer prevention
- Research techniques:Making protocols for studies. (Statistical) analysis of results
- Users of research expertise:Other researchers in the field.StudentsPharma and Biotech companies
Affiliations
- Center for Oncological Research (CORE) (Research group)
Member
From1 Jan 2019 → Today - Molecular Imaging, Pathology, Radiotherapy & Oncology (MIPRO) (Research group)
Responsible
From1 Oct 2009 → 31 Dec 2018
Projects
1 - 10 of 58
- Center for Proteomics (CfP).From1 Jan 2022 → TodayFunding: BOF - research organisations
- Neuroendocrine neoplasmsFrom1 Nov 2021 → TodayFunding: Nonprofit institution or equivalents
- Towards individualized treatment prediction and real-time follow-up of metastatic colorectal cancer patients using methylation biomarkersFrom1 Nov 2021 → TodayFunding: FWO Strategic Basic Research Grant
- Investigation to reveal the immunerReaction upon COVID-vaccination in the Belgian cancer population: COVID protection and vaccine safety (REAL-V).From1 Oct 2021 → TodayFunding: Nonprofit institution or equivalents
- A novel photoelectrochemical detection technology for molecular cancer biomarkers.From1 Sep 2021 → TodayFunding: IOF - technology validation in lab
- Combining targeted therapy and immunotherapy to improve survival and quality of life of head and neck cancer patients.From1 Mar 2021 → TodayFunding: Nonprofit institution or equivalents
- Investigating drug repurposing and next-generation immune checkpoints to cure the incurable: novel strategies to treat pancreatic cancer.From1 Nov 2020 → TodayFunding: FWO Strategic Basic Research Grant
- Screening and early detection of colorectal cancer and breast cancer in liquid biopsies using a newly-developed multi-regional methylation assay.From1 Nov 2020 → TodayFunding: FWO Strategic Basic Research Grant
- Rationally designed drug combination screen in more physiologically relevant in vitro organoid models: can we improve personalized therapy for pancreatic cancer?From1 Nov 2020 → TodayFunding: FWO Strategic Basic Research Grant
- Improving colorectal cancer detection and treatment follow-up through the development of a novel methylation assay.From1 Nov 2020 → TodayFunding: Nonprofit institution or equivalents
Publications
1 - 10 of 269
- Longitudinal copy-number alteration analysis in plasma cell-free DNA of neuroendocrine neoplasms is a novel specific biomarker for diagnosis, prognosis, and follow-up(2022)
Authors: Gitta Boons, Timon Vandamme, Laura Mariën, Willem Lybaert, Tim Rondou, Konstantinos Papadimitriou, Katrien Janssens, Bart op de Beeck, Marc Simoens, Wim Demey, et al.
Pages: 338 - 349 - Excellent response to MEK inhibition in an AGK-BRAF gene fusion driven carcinoma(2022)
Authors: Andreas Domen, Carl Van Paesschen, Suzan Lambin, Patrick Pauwels, Marika Rasschaert, E.V.A. Segelov, Marc Peeters, Hans Prenen
Pages: 373 - 379 - Clinical implications of isolated troponinemia following immune checkpoint inhibitor therapy(2021)
Authors: D. Vervloet, Constantijn Franssen, Lieselot Croes, F. Gremonprez, Hans Prenen, Marc Peeters, Christof Vulsteke
Number of pages: 9 - Expected medium- and long-term impact of the COVID-19 outbreak in oncology(2021)
Authors: Concetta Elisa Onesti, Marco Tagliamento, Giuseppe Curigliano, Nadia Harbeck, Rupert Bartsch, Hans Wildiers, Vivianne Tjan-Heijnen, Miguel Martin, Sylvie Rottey, Daniele Generali, et al.
Pages: 162 - 172 - Pancreatic neuroendocrine neoplasms(2021)Edition: 99Volume: 99
Authors: Timon Vandamme, L.J. Hofland, Patrick Pauwels, Marc Peeters, K. Op de Beeck
Number of pages: 303 - Evaluation of a new online cognitive assessment tool in breast cancer survivors with cognitive impairment(2021)
Authors: Anne Bellens, Ella Roelant, Bernard Sabbe, Marc Peeters, Peter Van Dam
Number of pages: 11 - A systematic review on poly(I:C) and poly-ICLC in glioblastoma(2021)
Authors: Jorrit De Waele, Sanne van der Heijden, Zwi Berneman, Marc Peeters, Filip Lardon, An Wouters, Evelien Smits
Number of pages: 20 - Epidermal growth factor as a potential prognostic and predictive biomarker of response to platinum-based chemotherapy(2021)
Authors: Margot Geens, Sofie Stappers, Heleen Konings, Benedicte De Winter, Pol Specenier, Jan van Meerbeeck, Gert Verpooten, Steven Abrams, Annelies J R Janssens, Marc Peeters, et al.
Number of pages: 13 - Meeting the challenges in cancer care management during the SARS-Cov-2 pandemic(2021)
Authors: Marika Rasschaert, Pieterjan Vanclooster, Laura Depauw, Tim Mertens, Ella Roelant, Elke Coenen, Sébastien Anguille, Annelies J R Janssens, Peter Van Dam, Marc Peeters
Number of pages: 9 - Immunoglobin G/total antibody testing for SARS-CoV-2(2021)
Authors: Peter Van Dam, Manon Huizing, Ella Roelant, An Hotterbeekx, Fien De Winter, Samir Kumar-Singh, Pieter Moons, Zainab Amajoud, Christof Vulsteke, Lieselot Croes, et al.
Pages: 328 - 339